MedPath

Effects of Sulforaphane on Normal Prostate Tissue

Phase 1
Completed
Conditions
Prostate Cancer
Interventions
Drug: High Sulforaphane Extract (Broccoli Sprout Extract)
Drug: Microcrystalline Cellulose NF (placebo)
Registration Number
NCT00946309
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

The investigators proposed to identify the biological effects of a high-sulforaphane broccoli sprout extract in normal prostate tissue.

The investigators hypothesize that consumption of high-sulforaphane broccoli sprout extract every other day will inhibit growth of prostate cancer cells.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
45
Inclusion Criteria
  • Men aged 40-75 years
  • Low or intermediate grade prostate cancer (as defined by Gleason sum less than or equal to 7) and clinical stage T1 or T2
  • Serum Prostate specific antigen less than 20 ng/ml
  • Have elected radical prostatectomy, Brachytherapy or active surveillance as their primary treatment
Exclusion Criteria
  • No current physician diagnosed disease (including but not limited to): kidney disease requiring dialysis, cognitive deficits, substance abuse
  • BMI < 18.5 kg/m2 or > 40 kg/m2
  • Use of any hormonal treatments, including but not limited to testosterone
  • Any previous cancer diagnosis or treatment within the previous five years, excluding non-melanoma skin cancer
  • Inability or unwillingness to eat a diet that is free of Brassica vegetables for the duration of the study
  • Use of any dietary supplements other than a multivitamin (including herbal preparations)
  • Allergy to cruciferous vegetables or any of the specific fillers used in the placebo
  • Usual consumption of > 5 servings per week of Brassica vegetables

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High Sulforaphane ExtractHigh Sulforaphane Extract (Broccoli Sprout Extract)-
PlaceboMicrocrystalline Cellulose NF (placebo)-
Primary Outcome Measures
NameTimeMethod
Gene Expression of Phase II EnzymesBaseline and 5 weeks

Change in Phase II enzyme expression

DHT LevelsBaseline and 5 weeks

Change in serum dihydrotestosterone (DHT) levels

Testosterone LevelsBaseline and 5 weeks

Change in testosterone (T) levels

DNA OxidationFive weeks

Prostate tissue 8-hydroxy-2'-deoxyguanosine (8OHdG) levels

Lipid OxidationBaseline and 5 weeks

Blood F2 Isoprostane levels

3-alpha-diol Gluconate LevelsBaseline and 5 weeks

Change in serum 3-alpha-diol gluconate(3α-DG) levels

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

VA Puget Sound

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath